← back to search

Fengkai Xu

Sun Yat-sen University · CN
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer-related gene regulation, Ferroptosis and cancer prognosis, RNA modifications and cancer, and Radiomics and Machine Learning in Medical Imaging.
h-index
19
citations
1,363
works
49
NIH funding
primary concept
email

Recent publications

Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma
Cancer Letters 2025cited by 7position: middledoi
UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment
Nature Communications 2024cited by 51position: middledoi
KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4
Communications Biology 2023cited by 37position: middledoi
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer
Cancer Immunology Immunotherapy 2022cited by 104position: middledoi
BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
Journal of Cancer 2022cited by 29position: middledoi
Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma
Briefings in Bioinformatics 2020cited by 149position: middledoi
Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma
Cell Communication and Signaling 2020cited by 47position: firstdoi
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies
BMC Cancer 2019cited by 86position: middledoi
Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data
Scientific Reports 2018cited by 136position: middledoi
Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex
Cancer Letters 2018cited by 70position: middledoi
Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway
International Journal of Biological Sciences 2018cited by 43position: firstdoi
B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice
Hepatology 2015cited by 81position: middledoi
DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling
Clinical Cancer Research 2014cited by 116position: middledoi
USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma
Tumor Biology 2014cited by 82position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jie Gu · Tongji University9 papers (2014–2024)Di Ge · Nanjing University of Information Science and Technology7 papers (2014–2025)Chunlai Lu · PLA Navy General Hospital7 papers (2014–2023)Qiaoliang Zhu · Shanghai Medical College of Fudan University7 papers (2018–2022)Di Ge · Sun Yat-sen University5 papers (2018–2023)Yiwei Chu · Fudan University5 papers (2014–2020)Yin Li · Hebei Medical University5 papers (2018–2024)Wei Mao · Peking University Shenzhen Hospital3 papers (2018–2020)Chunlai Lu · Sun Yat-sen University3 papers (2019–2024)Ronghua Liu · Fudan University3 papers (2014–2018)Ronghua Liu · Fudan University3 papers (2014–2020)Guangyin Zhao · Shanghai Medical College of Fudan University2 papers (2014–2023)Guangyao Shan · Fudan University2 papers (2023–2025)Zhonghe Liu · Fudan University2 papers (2018–2020)Guoshu Bi · Sun Yat-sen University2 papers (2023–2025)Jiaqi Liang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2023–2025)Lin Wang · Southwest University2 papers (2018–2020)Xiaoming Liu · Beijing Institute of Technology2 papers (2014–2015)Zongwu Lin · Fudan University2 papers (2014–2018)Cheng Zhan · Sun Yat-sen University2 papers (2023–2025)